Journal of Urologic Oncology

Complex Epidemiology of Prostate Cancer in Asian Countries Kagenori Ito, Takahiro Kimura J Urol Oncol. 2023;21(1):5-13. Cited By 2 Reivew Article Mar 31, 2023 Full text PubReader ePub PDF	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades Sang Heon Han, Hyeong Dong Yuk J Urol Oncol. 2023;21(1):32-44. Cited By 2 Original Article Mar 31, 2023 The Landscape of Epidemiology in Urologic Cancers Full text PubReader ePub PDF Supplementary Material
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use Byung Kwan Park J Urol Oncol. 2023;21(2):106-111. Cited By 2 Invited Review Jul 31, 2023 mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness Full text PubReader ePub PDF	Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer Jaemin Jo, Sanghoon Han, Jung-Sik Huh Korean J Urol Oncol. 2021;19(1):23-29. Cited By 1 Review Article Feb 26, 2021 Full text PubReader ePub PDF
The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model Seok Ju Hong, Gwang Yong Hwang, Su Jeong Kang, et al. Korean J Urol Oncol. 2021;19(1):40-47. Cited By 1 Original Article Feb 26, 2021 Full text PubReader ePub PDF	Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer Je-Gun Joung, Joo-Young Park, So-Yun Yang, et al. Korean J Urol Oncol. 2021;19(2):101-108. Cited By 1 Review Article May 31, 2021 Full text PubReader ePub PDF
Predictive Factors of De Novo Overactive Bladder After Radical Prostatectomy in Patients With Clinically Localized Prostate Cancer: A Prospective Observational Study Jun Nyung Lee, Sang Won Kim, Kyeong-Hyeon Byeon, et al. Korean J Urol Oncol. 2021;19(2):109-116. Cited By 1 Original Article May 31, 2021 Full text PubReader ePub PDF	Predictive Factors for Acute Urinary Retention After Transperineal Template-Guided Mapping Biopsy Si Hyun Sung, Chung Un Lee, Jae Hoon Chung, et al. Korean J Urol Oncol. 2021;19(3):148-154. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF
Investigation of Information Acquisition Channel for Prostate Cancer High-Risk Group Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al. Korean J Urol Oncol. 2021;19(3):174-182. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF Supplementary Material	Usefulness of Prostate-Specific Antigen Density as an Indicator for Recommending Prebiopsy Magnetic Resonance Imaging to Prevent Missed Prostate Cancer Diagnoses Jin Hyung Jeon, Kyo Chul Koo, Byung Ha Chung, et al. Korean J Urol Oncol. 2021;19(3):155-163. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF
Machine Learning Techniques in Prostate Cancer Diagnosis According to Prostate-Specific Antigen Levels and Prostate Cancer Gene 3 Score Roberto Passera, Stefano De Luca, Cristian Fiori, et al. Korean J Urol Oncol. 2021;19(3):164-173. Cited By 1 Original Article Aug 31, 2021 Full text PubReader ePub PDF	A Study on Metabolic Health Status as a Risk Factor for Female Bladder Cancer Incidence: Analysis From the National Health Checkups Database of Korea Da Eun Han, Sun Tae Ahn, Jong Wook Kim, et al. Korean J Urol Oncol. 2021;19(4):223-231. Cited By 1 Original Article Nov 25, 2021 Full text PubReader ePub PDF
The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer Jae Young Joung, Sung Han Kim Korean J Urol Oncol. 2022;20(1):1-11. Cited By 1 Review Article Feb 24, 2022 Full text PubReader ePub PDF	2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS) Chan Ho Lee, Minyong Kang, Cheol Kwak, et al. Korean J Urol Oncol. 2022;20(3):151-162. Cited By 1 Review Article Aug 25, 2022 Full text PubReader ePub PDF
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer Jeong Hee Hong Korean J Urol Oncol. 2022;20(4):207-222. Cited By 1 Review Article Nov 30, 2022 Full text PubReader ePub PDF	A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al. Korean J Urol Oncol. 2022;20(4):265-272. Cited By 1 Original Article Nov 30, 2022 Full text PubReader ePub PDF Supplementary Material
Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, et al. J Urol Oncol. 2023;21(1):45-52. Cited By 1 Original Article Mar 31, 2023 Full text PubReader ePub PDF Supplementary Material	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al. J Urol Oncol. 2023;21(1):70-78. Cited By 1 Original Article Mar 31, 2023 Full text PubReader ePub PDF
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening Jung Sik Huh, Kyung Kgi Park J Urol Oncol. 2023;21(2):121-127. Cited By 1 Original Article Jul 31, 2023 mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness Full text PubReader ePub PDF	Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery? Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, et al. J Urol Oncol. 2023;21(2):140-147. Cited By 1 Invited Review Jul 31, 2023 Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma Full text PubReader ePub PDF Supplementary Material
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance Chang Wook Jeong J Urol Oncol. 2023;21(2):97-105. Cited By 1 Invited Review Jul 31, 2023 mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness Full text PubReader ePub PDF	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials Sang Hun Song, Jong Jin Oh J Urol Oncol. 2023;21(2):154-164. Cited By 1 Invited Review Jul 31, 2023 Trimodality Therapy and Immuno-Oncology for Bladder Cancer Full text PubReader ePub PDF
Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma Dongsu Kim, Bumjin Lim, Jungyo Suh, et al. J Urol Oncol. 2023;21(2):148-153. Cited By 1 Original Article Jul 31, 2023 Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma Full text PubReader ePub PDF	The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma Sung Kyung Choi, Chan Hoon Gwak, Jungyo Suh, et al. J Urol Oncol. 2023;21(2):174-180. Cited By 1 Original Article Jul 31, 2023 Trimodality Therapy and Immuno-Oncology for Bladder Cancer Full text PubReader ePub PDF
Impact of Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Extension According to the National Comprehensive Cancer Network Risk Stratification in Prostate Cancer Jae Hoon Kang, Jun-Koo Kang, Jae-Wook Chung, et al. J Urol Oncol. 2023;21(2):112-120. Cited By 1 Topic Article Jul 31, 2023 mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness Full text PubReader ePub PDF Supplementary Material	Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, et al. J Urol Oncol. 2023;21(2):165-173. Cited By 1 Original Article Jul 31, 2023 Trimodality Therapy and Immuno-Oncology for Bladder Cancer Full text PubReader ePub PDF Supplementary Material
Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer Hyunho Han, Minyong Kang, Seok-Soo Byun, et al. J Urol Oncol. 2023;21(2):128-139. Cited By 1 Invited Review Jul 31, 2023 Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma Full text PubReader ePub PDF	Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al. J Urol Oncol. 2023;21(3):183-199. Cited By 1 Invited Review Nov 30, 2023 Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma Full text PubReader ePub PDF
Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis Jin Noh, Sang Hun Song, Gyoohwan Jung, et al. J Urol Oncol. 2023;21(3):200-207. Cited By 1 Topic Article Nov 30, 2023 Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma Full text PubReader ePub PDF	The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects Hyerim Ha, Joo Han Lim J Urol Oncol. 2023;21(3):208-216. Cited By 1 Invited Review Nov 30, 2023 Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma Full text PubReader ePub PDF

4,313	Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer
4,174	Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer
4,010	The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment
3,980	Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2
3,941	Laparoscopic Radical Cystectomy With Intracorporeal Orthotopic Neobladder Reconstruction: An Initial Experience of Modified Studer Reconstruction Techniques

Cited By 2	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 2	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 1	Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer
Cited By 1	The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model